{"id":207295,"name":"CONNECT4STRATEGIES ON BEHALF OF FCS - FAMILIAL CHYLOMICRONEMIA","slug":"connect4strategies-on-behalf-of-fcs-familial-chylomicronemia","state":"MD","country":"United States of America","description":"Patient advocacy organization","totalSpending":200000,"filings":12,"yearlySpending":[{"year":2020,"income":40000},{"year":2021,"income":60000},{"year":2022,"income":100000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"HCR","display":"Health Issues"}],"firms":["ALPINE GROUP PARTNERS, LLC."],"lobbyists":["COURTNEY JOHNSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020\nH.R. 8467, Access to Rare Indications Act of 2020\nIssues related to utilization management tools and rare diseases\nH.R. 8467, Access t","H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020\nH.R. 8467, Access to Rare Indications Act of 2020\nIssues related to utilization management tools and rare diseases\nH.R. 8467, Access t","H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020\nH.R. 8467, Access to Rare Indications Act of 2020\nIssues related to utilization management tools and rare diseases","H.R. 8467, Access to Rare Indications Act of 2020","H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020\nH.R. 8467, Access to Rare Indications Act of 2020\nIssues related to utilization management tools and rare diseases"]}